niacinamide and arsenic

niacinamide has been researched along with arsenic in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19905 (41.67)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Morgenstern, N; Peters, L; Smith, JM1
Henderson, LM; Lan, SJ1
Francis, SH; Meriwether, BP; Park, JH1
Bechara, EJ; Cilento, G1
DIOGUARDI, N; VILLA, L1
Cui, YZ; Luo, RC; Wu, J; Zhang, H1
Bechelli, J; Ifthikharuddin, JJ; Jordan, CT; Liesveld, JL; Lu, C; Messina, P; Mulford, D; Phillips Ii, GL; Rosell, KE1
Allensworth, JL; Devi, GR; Diehl, AM; Lyerly, HK; Morse, MA; Rangwala, F; Smith, GR; Thomas, Z; Williams, KP1
He, C; Jiang, H; Jiang, X; Ma, L; Sun, X; Xu, L; Zhai, B; Zhao, D1
Chen, C; Hu, H; Li, H1
Goldberg, M; Hashim, P; Levitt, J; Verhave, B1
Chen, S; Cheng, W; He, T; Liu, J; Wang, X; Wang, Y; Zhang, J1

Trials

1 trial(s) available for niacinamide and arsenic

ArticleYear
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.
    Cancer investigation, 2011, Volume: 29, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Benzenesulfonates; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cytarabine; Cytokines; Farnesyltranstransferase; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Niacinamide; Oxides; Phenylurea Compounds; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyridines; Sorafenib

2011

Other Studies

11 other study(ies) available for niacinamide and arsenic

ArticleYear
Inhibition of the renal tubular transport and excretion of tetraethylammonium and N1-methylnicotinamide by non-nitrogenous onium compounds.
    The Journal of pharmacology and experimental therapeutics, 1967, Volume: 158, Issue:3

    Topics: Aminohippuric Acids; Animals; Antimony; Arsenic; Biological Transport; Carbon Isotopes; Chickens; Dogs; Kidney; Kidney Tubules; Niacinamide; Onium Compounds; Oxygen Consumption; Phosphorus; Receptors, Drug; Sulfur; Tetraethylammonium Compounds

1967
Uptake of nicotinic acid and nicotinamide by rat erythrocytes.
    The Journal of biological chemistry, 1968, Jun-25, Volume: 243, Issue:12

    Topics: Animals; Arsenicals; Biological Transport; Carbon Isotopes; Erythrocytes; Fluorides; Glucose; Iodoacetates; Niacinamide; Nicotinic Acids; Phosphates; Pyridines; Rats; Temperature; Time Factors

1968
Interaction between adenine nucleotides and 3-phosphoglyceraldehyde dehydrogenase. II. A study of the mechanism of catalysis and metabolic control of the multi-functional enzyme.
    The Journal of biological chemistry, 1971, Sep-10, Volume: 246, Issue:17

    Topics: Acetates; Acylation; Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arsenic; Autoradiography; Binding Sites; Carbon Isotopes; Catalysis; Chemical Phenomena; Chemistry; Cyclic AMP; Depression, Chemical; Diphosphates; Electrophoresis; Enzyme Activation; Glyceraldehyde-3-Phosphate Dehydrogenases; Guanine Nucleotides; Hydrogen-Ion Concentration; Hydrolysis; Muscles; NAD; Niacinamide; Nitrophenols; Nucleoside Diphosphate Sugars; Pepsin A; Peptides; Phosphoric Acids; Protein Binding; Rabbits; Ribose; Stimulation, Chemical

1971
Phosphate catalysis in the autoxidation of 1-n-propyl-6-hydroxy-1,4,5,6-tetrahydronicotinamide. A model for adenosine triphosphate formation.
    Biochemistry, 1971, May-11, Volume: 10, Issue:10

    Topics: Adenosine Triphosphate; Aniline Compounds; Arsenic; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Chromatography, Paper; Deuterium; Kinetics; NAD; NADP; Niacinamide; Organophosphorus Compounds; Oxidation-Reduction; Oxygen Consumption; Phosphates; Phosphoric Acids; Potentiometry; Pyridinium Compounds; Spectrophotometry; Ultraviolet Rays

1971
[Importance of the alimentation factor in liver respiration in rats in the presence of nicotinamide].
    Minerva medica, 1954, Nov-14, Volume: 45, Issue:91

    Topics: Animals; Arsenicals; Diet; Humans; Liver; Niacin; Niacinamide; Nicotinic Acids; Rats

1954
[Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Oxides; Phenylurea Compounds; Pyridines; Sorafenib

2008
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    BMC cancer, 2012, Sep-10, Volume: 12

    Topics: Adult; AMP-Activated Protein Kinases; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Thymidylate Synthase; Time Factors

2012
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Niacinamide; Oxides; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib

2015
[Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib

2015
Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil
    Journal of drugs in dermatology : JDD, 2019, May-01, Volume: 18, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Antimetabolites, Antineoplastic; Arsenic; Bowen's Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Niacinamide; Skin Neoplasms; Water Pollutants; Water Supply

2019
Integrated metabolomics and network pharmacology revealing the mechanism of arsenic-induced hepatotoxicity in mice.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2023, Volume: 178

    Topics: Animals; Arsenic; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Humans; Metabolomics; Mice; Network Pharmacology; Niacinamide; Phosphatidylinositol 3-Kinases

2023
chemdatabank.com